Form D · Private Equity Fund

Blackstone Life Sciences V (Lux) SCSp

New York, NY · CIK 0001797872

Offering snapshot reported Jul 9, 2020 · SEC filing

Reported sold
$4.61B
Offering amount: $4.61B
Investors reported
20
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 31, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.3B$4.61BJan 9, 2020: $3,444,130,000.00Jan 9, 2020Jul 9, 2020: $4,605,000,000.00Jul 9, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,444,130,000 → $4,605,000,000
  • Reported investors8 → 20

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 9, 2020Amendment$4,605,000,000$1,160,870,000vs Jan 9, 202020SEC filing
Jan 9, 2020Initial$3,444,130,000No comparison8SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-357600
Total offering amount and total amount sold includes the General Partner's commitment as well as sales in parallel funds.

Source: Form D, filed Jul 9, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BLACKSTONE LIFE SCIENCES V (LUX) SCSP

Investment adviser: BLACKSTONE LIFE SCIENCES ADVISORS L.L.C.

Gross asset value
$587M
Beneficial owners
21
ADV minimum commitment
$10M

Reported in Form ADV on Mar 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CACEIS INVESTOR SERVICES BANK S.A. ESCH-SUR-ALZETTE, Luxembourg Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor DELOITTE AUDIT, S.A.R.L. LUXEMBOURG CITY, Luxembourg
Custodian BANK OF AMERICA, N.A WILMINGTON, Delaware, United States Related to adviser: No
Custodian CACEIS INVESTOR SERVICES BANK S.A. ESCH-SUR-ALZETTE, Luxembourg Related to adviser: No
Custodian CITIBANK, N.A. LONDON, United Kingdom Related to adviser: No
Custodian JPMORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No
Custodian UBS FINANCIAL SERVICES INC. BOSTON, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

DELOITTE AUDIT, S.A.R.L.
PCAOB 1287

Filing source

Form ADV 2068503 · Mar 30, 2026 · Schedule D 7.B.(1), fund 805-6601792131

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph Baratta Executive
N/A N/A Blackstone Life Sciences Associates V L.P. Promoter
N/A N/A Blackstone Life Sciences Associates V (Lux) S.A R.L. Promoter
N/A N/A Blackstone Life Sciences Associates V (Lux) S.? R.L. Promoter
N/A N/A Bxls V L.L.C. Promoter
John G. Finley Executive
Nick Galakatos Executive
Robert Liptak Executive
Christopher Placca Executive
Omar Rehman Executive
Matthew Skurbe Executive
Christopher Striano Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
345 Park Avenue
New York, NY, 10154